Shandong Tumor Hospital
Clinical trials sponsored by Shandong Tumor Hospital, explained in plain language.
-
New combo therapy tested for tough stomach cancers
Disease control Recruiting nowThis study is testing whether combining two drugs, carilizumab and albumin paclitaxel, can help control advanced stomach cancer in patients whose first treatment has stopped working. It will include 40 adults whose cancer progressed after initial chemotherapy, with or without imm…
Phase: PHASE2 • Sponsor: Shandong Tumor Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for tough stomach cancers: trial tests aggressive drug combo
Disease control Recruiting nowThis study is for people with advanced stomach cancer that has gotten worse after their first treatment. It will test if a new three-drug combination works better and is safe enough compared to a standard single chemotherapy drug. The goal is to see if the new combination can bet…
Phase: PHASE2 • Sponsor: Shandong Tumor Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:42 UTC